The Role of α-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications
The DOI matches its Crossref record; 313 of the 323 references it cites were found in a registry or an index.
Abstract
The hyperglycemic activity of pancreatic extracts was encountered some 80 yr ago during efforts to optimize methods for the purification of insulin. The hyperglycemic substance was named "glucagon," and it was subsequently determined that glucagon is a 29-amino acid peptide synthesized and released from pancreatic alpha-cells. This article begins with a brief overview of the discovery of glucagon and the contributions that somatostatin and a sensitive and selective assay for pancreatic (vs. gut) glucagon made to understanding the physiological and pathophysiological roles of glucagon. Studies utilizing these tools to establish the function of glucagon in normal nutrient homeostasis and to document a relative glucagon excess in type 2 diabetes mellitus (T2DM) and precursors thereof are then discussed. The evidence that glucagon excess contributes to the development and maintenance of fasting hyperglycemia and that failure to suppress glucagon secretion contributes to postprandial hyperglycemia is then reviewed. Although key human studies are emphasized, salient animal studies highlighting the importance of glucagon in normal and defective glucoregulation are also described. The past eight decades of research in this area have led to development of new therapeutic approaches to treating T2DM that have been shown to, or are expected to, improve glycemic control in patients with T2DM in part by improving alpha-cell function or by blocking glucagon action. Accordingly, this review ends with a discussion of the status and therapeutic potential of glucagon receptor antagonists, alpha-cell selective somatostatin agonists, glucagon-like peptide-1 agonists, and dipeptidyl peptidase-IV inhibitors. Our overall conclusions are that there is considerable evidence that relative hyperglucagonemia contributes to fasting and postprandial hyperglycemia in patients with T2DM, and there are several new and emerging pharmacotherapies that may improve glycemic control in part by ameliorating the hyperglycemic effects of this relative glucagon excess.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in patients with T2DM elevated plasma glucagon levels have been observed in the fasting state, and defective suppression of glucagon secretion exists in the postprandial state, resulting in elevated plasma glucagon levels (7)”
From Mathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test (2021) · cites this paper as [7]
In the citing paper
“dysregulated α-cell release of glucagon, manifest as increased fasting glucagon concentrations and a failure to adequately suppress glucagon release following meal ingestion, contributes to the development of hyperglycaemia34.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [34]
Citations
Cites
Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., & Guillemin, R. (1973) · Science · doi:10.1126/science.179.4068.77 · Cited by 3,532
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
Methods of Hormone Radioimmunoassay
(1978) · Elsevier eBooks · doi:10.1016/b978-0-123-79260-0.x5001-8 · Cited by 2,077
Glucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928
DeFronzo, R. A., Ratner, R. E., Han, J., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1092 · Cited by 1,559
(2004) · doi:10.1016/s0092-8674(04)00452-0 · Cited by 1,356
Buse, J. B., Henry, R. R., Han, J., Kim, D. D., Fineman, M. S., Baron, A. D., & for the Exenatide-113 Clinical Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2628 · Cited by 1,346
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297
Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
Mentlein, R. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00089-0 · Cited by 1,272
Research works printed but not linked: 9
- 2005, Sandostatin LAR depot (octreotide acetate for injectable suspension).
- 2005, Byetta (exenatide injection)[prescribing information].
- Pratley, 2005, Dipeptidyl peptidase-4 inhibition in type 2 diabetes mellitus., Sci Med, 10, 13
- Villhauer, 2001, DPP-IV inhibition and therapeutic potential., Annu Rep Med Chem, 36, 191
- Balas, J Clin Endocrinol Metab
- Dejager, Horm Metab Res
- Bosi, Diabetes Care
- Rosenstock, Diabetes Obes Metab
- Garber, Diabetes Obes Metab
Cited by
Items 201–300 of 421
Atanasovska, E., Tasic, V. B., Slaninka-Miceska, M., Alabakovska, S. B., Zafirov, D., Kostova, E., Pavlovska, K., Filipče, V., & Labacevski, N. (2014) · PubMed · Cited by 21
Stamenkovic, J., Andersson, L. E., Adriaenssens, A. E., Bagge, A., Sharoyko, V. V., Gribble, F. M., Reimann, F., Wollheim, C. B., Mulder, H., & Spégel, P. (2015) · Biochemical Journal · doi:10.1042/bj20140697 · Cited by 21
Khajavi, N., Biebermann, H., Tschöp, M., & DiMarchi, R. (2017) · Endocrine Development · doi:10.1159/000475737 · Cited by 16
Marroquí, L., Batista, T. M., González, A., Vieira, E. C., Rafacho, A., Colleta, S. J., Taboga, S. R., Boschero, A. C., Nadal, Á., Carneiro, E. M., et al. (2012) · Endocrinology · doi:10.1210/en.2011-1623 · Cited by 20
Wang, H., Cao, J., Su, J., Wang, X., Wang, X., Zhang, D., & Wang, X. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00690-z · Cited by 20
Isosteviol Has Beneficial Effects on Palmitate-Induced α-Cell Dysfunction and Gene Expression
Chen, X., Hermansen, K., Xiao, J., Bystrup, S., O’Driscoll, L., & Jeppesen, P. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034361 · Cited by 20
Postprandial Suppression of Glucagon Secretion: A Puzzlement
Geary, N. (2017) · Diabetes · doi:10.2337/dbi16-0075 · Cited by 19
Alpha cell function interacts with diet to modulate prediabetes and Type 2 diabetes
Roncero‐Ramos, I., Jiménez-Lucena, R., Alcala-Diaz, J. F., Vals‐Delgado, C., Larriva, A. P. A.-D., Rangel-Zúñiga, O. A., Leon‐Acuña, A., Malagón, M. M., Delgado‐Lista, J., Pérez‐Martínez, P., et al. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.08.012 · Cited by 19
Tributyltin exposure disturbs hepatic glucose metabolism in male mice
Xu, J., Ou, K., Chen, C., Li, B., Guo, J., Zuo, Z., & Wang, C. (2019) · Toxicology · doi:10.1016/j.tox.2019.152242 · Cited by 19
Glucagon: The renewal of an old hormone in the pathophysiology of diabetes (胰升糖素:一种老激素在糖尿病病理生理中的新作用)
Gosmain, Y., Masson, M. H., & Philippé, J. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12022 · Cited by 19
The role of α-, δ- and F cells in insulin secretion and action
Yovos, J. G. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70009-2 · Cited by 19
Meyer‐Gerspach, A. C., Cajacob, L., Riva, D., Herzog, R., Drewe, J., Beglinger, C., & Wölnerhanssen, B. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150803 · Cited by 19
Patterns of plasma glucagon dynamics do not match metabolic phenotypes in young women
Gar, C., Rottenkolber, M., Sacco, V., Moschko, S., Banning, F., Hesse, N., Popp, D., Hübener, C., Seissler, J., & Lechner, A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02014 · Cited by 18
Glucagon changes substrate preference in gluconeogenesis
Xu, H., Wang, Y., Kwon, H., Shah, A. M., Kalemba, K. M., Su, X., He, L., & Wondisford, F. E. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102708 · Cited by 18
Soty, M., Chilloux, J., Delalande, F., Zitoun, C., Bertile, F., Mithieux, G., & Gautier‐Stein, A. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00110 · Cited by 18
Wang, X., Xu, F., Cheng, M., Wang, X., Zhang, D., Zhao, L., Cai, H.-L., Huang, H., Chen, T., Zhang, X., et al. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0201 · Cited by 18
Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
Alsahli, M., & Gerich, J. E. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch10 · Cited by 18
Self-citationSeino, Y., Rasmussen, M. F., Clauson, P., & Kaku, K. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00193.x · Cited by 17
Increased alpha and beta cell mass during mouse pregnancy is not dependent on transdifferentiation
Szlapinski, S. K., Bennett, J., Strutt, B. J., & Hill, D. J. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220972686 · Cited by 17
Islet Cell Response to High Fat Programming in Neonate, Weanling and Adolescent Wistar Rats
Cerf, M. E., & Louw, J. (2014) · PubMed · doi:10.6092/1590-8577/1534 · Cited by 17
Silvestre, M. P., Goode, J. P., Vlaskovsky, P., McMahon, C., Tay, A., & Poppitt, S. (2017) · Obesity Reviews · doi:10.1111/obr.12631 · Cited by 17
Pérez, Á., Rojas, P., Carrasco, F., Basfi-fer, K., Pérez‐Bravo, F., Codoceo, J., Inostroza, J., & Ruz, M. (2018) · Biological Trace Element Research · doi:10.1007/s12011-018-1249-6 · Cited by 17
Hammana, I., Coderre, L., Potvin, S., Costa, M., Berthiaume, Y., Lavoie, A., Chiasson, J. L., Levy, E. H., & RABASA-LHORET, R. P. R. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.11.002 · Cited by 17
Kim, W.-D., Lee, Y., Kim, M.-H., Jung, S.-Y., Son, W., Yoon, S.-J., & Lee, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050954 · Cited by 17
McGill, J. B. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.01.1954 · Cited by 17
Costa, R. P. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/71gw-dc16 · Cited by 17
Irwin, N., Franklin, Z. J., & O'Harte, F. P. M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.041 · Cited by 16
Responses to cholecystokinin in the ventromedial nucleus of the rat hypothalamus in vivo
Sabatier, N., & Leng, G. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07144.x · Cited by 16
Acute Glucagon Induces Postprandial Peripheral Insulin Resistance
Patarrão, R. S., Lautt, W. W., & Macedo, M. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127221 · Cited by 16
FCoR-Foxo1 Axis Regulates α-Cell Mass through Repression of Arx Expression
Kodani, N., Nakae, J., Kobayashi, M., Kikuchi, O., Kitamura, T., & Itoh, H. (2019) · iScience · doi:10.1016/j.isci.2019.100798 · Cited by 15
Åhrén, B. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13564 · Cited by 15
Franklin, Z. J., O'Harte, F. P. M., & Irwin, N. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0224 · Cited by 15
Glucose‐induced inhibition of insulin secretion
Hellman, B., & Grapengiesser, E. (2013) · Acta Physiologica · doi:10.1111/apha.12217 · Cited by 15
Phenotypes of streptozotocin-induced gestational diabetes mellitus in mice
Takahashi, N., Ichii, O., Hiraishi, M., Namba, T., Otani, Y., Nakamura, T., & Kon, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302041 · Cited by 14
Glucagon in metabolic disease: a mini-review of emerging multi-organ roles beyond glycemic control
Lee, S. H., Park, H. Y., Yun, J. H., & Kyoung, E. J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1645041 · Cited by 14
Lau, Y. Y., Ma, P., Gibiansky, L. V., Komorowski, R., Wang, J., Wang, G., Yan, H., Véniant, M. M., & Kakkar, T. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9150-z · Cited by 14
Rosenstock, J., Robins, D. A., Duffin, K. L., Wilson, J. M., Lin, Y., Banerjee, H., Eyde, S., KAZDA, C. M., Кониг, М., & Mather, K. J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70022 · Cited by 13
Sah, S. K., Samuel, V. P., Dahiya, S., Singh, Y., Gilhotra, R. M., Gupta, G., Mishra, A., Sharma, R. K., Kumar, G. S., Sreeharsha, N., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.04.022 · Cited by 13
Evidence for Glucagon Secretion and Function Within the Human Gut
Sun, E. W. L., Martin, A. M., de Fontgalland, D., Sposato, L., Rabbitt, P., Hollington, P., Wattchow, D. A., Colella, A. D., Chataway, T., Albrechtsen, N. J. W., et al. (2021) · Endocrinology · doi:10.1210/endocr/bqab022 · Cited by 13
Sionov, R. V., & Ahdut-HaCohen, R. (2023) · Biomedicines · doi:10.3390/biomedicines11092558 · Cited by 13
Goldenberg, R., Verma, S., Perkins, B. A., Gilbert, J. D., & Zinman, B. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.08.001 · Cited by 13
Olson, D. E., Campbell, A. G., Porter, M. H., Freeman, K. G., Kelso, E., Flatt, W. P., & Thulé, P. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.97 · Cited by 13
A computational systems analysis of factors regulating α cell glucagon secretion
Fridlyand, L. E., & Philipson, L. H. (2012) · Islets · doi:10.4161/isl.22193 · Cited by 12
Preproglucagon Products and Their Respective Roles Regulating Insulin Secretion
Bethea, M. M., Bozadjieva-Kramer, N., & Sandoval, D. A. (2021) · Endocrinology · doi:10.1210/endocr/bqab150 · Cited by 12
Screening of Metabolism-Disrupting Chemicals on Pancreatic α-Cells Using In Vitro Methods
dos Santos, R. S., Babiloni-Chust, I., Marroquí, L., & Nadal, Á. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010231 · Cited by 12
Subramanian, V., Bagger, J. I., Harihar, V., Holst, J. J., Knop, F. K., & Villsbøll, T. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00278.2023 · Cited by 12
Gupta, A., Al-Aubaidy, H. A., & Mohammed, B. I. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.03.013 · Cited by 12
Song, J., He, Q., Guo, X., Wang, L., Wang, J., Cui, C., Hu, H., Yang, M., Cui, Y., Zang, N., et al. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111445 · Cited by 12
Skrzypski, M., Kolodziejski, P. A., Pruszyńska‐Oszmałek, E., Wojciechowicz, T., Janicka, P., Krążek, M., Małek, E., Strowski, M. Z., & Nowak, K. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179807 · Cited by 12
Vasu, S., Moffett, R. C., McCluskey, J. T., Hamid, M., Irwin, N., & Flatt, P. R. (2013) · Gene Therapy · doi:10.1038/gt.2013.33 · Cited by 12
Maranghi, M., Carnovale, A., Durante, C., Tarquini, G., Tiseo, G., & Filetti, S. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.986457 · Cited by 12
Gustavsson, N., Seah, T., Lao, Y., Radda, G. K., Südhof, T. C., & Han, W. (2010) · Diabetologia · doi:10.1007/s00125-010-1950-2 · Cited by 13
Inadequate Glucagon Suppression During OGTT in Prediabetes: A Systematic Review and Meta-analysis
Chang, L., Liu, Y., Gu, Y., Yan, S., Ding, L., Liu, M. R., & He, Q. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae460 · Cited by 11
Does Incretin Agonism Have Sustainable Efficacy?
Janket, S., Chatanaka, M. K., Sohaei, D., Tamimi, F., Meurman, J. H., & Diamandis, E. P. (2024) · Cells · doi:10.3390/cells13221842 · Cited by 11
Lam, C. J., Rankin, M. M., King, K. B., Wang, M. C., Shook, B. C., & Kushner, J. A. (2019) · Diabetes · doi:10.2337/db18-1293 · Cited by 11
Yun, Y. S., Tajima, M., Takahashi, S., Takahashi, Y. K., Umemura, M., Nakano, H., Park, H. S., & Inoue, H. (2016) · Phytotherapy Research · doi:10.1002/ptr.5676 · Cited by 11
G protein-coupled receptors as regulators of pancreatic islet functionality
Thor, D. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119235 · Cited by 11
Infante, M., & Ricordi, C. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2168645 · Cited by 10
Song, J., Wang, L., Wang, L., Guo, X., He, Q., Chen, C., Hu, H., Zang, N., Yang, M., Yan, F., et al. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae038 · Cited by 10
Glucagon clearance is regulated by nutritional state: evidence from experimental studies in mice
Zhou, A., Pacini, G., Åhrén, B., & D’Argenio, D. Z. (2013) · Diabetologia · doi:10.1007/s00125-013-3148-x · Cited by 10
Chang, Y.-H., Katoh, M., Abdellatif, A. M., Xiafukaiti, G., Ibrahim, E. A. E., Ojima, M., Mizuno, S., Kuno, A., & Takahashi, S. (2019) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.19-0105 · Cited by 10
Huang, H., Shen, L., Huang, H., Zhao, L., Xu, F., Zhang, D., Zhang, X., Chen, T., Wang, X., Xie, Y., et al. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0149 · Cited by 10
A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment
Subramanian, V., Bagger, J. I., Holst, J. J., Knop, F. K., & Vilsbøll, T. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.911616 · Cited by 10
DLBS3233 extract, a novel insulin sensitizer with negligible risk of hypoglycemia: A phase-I study
Tjandrawinata, R. R., Suastika, K., & Nofiarny, D. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497721 · Cited by 10
Hamasaki, H., & Morimitsu, S. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.08.108 · Cited by 10
Glucagon's yin and yang effects on hepatic glucose production
Edgerton, D. S., & Cherrington, A. D. (2013) · Nature Medicine · doi:10.1038/nm.3202 · Cited by 10
Zheng, H.-L., Xing, Y., Li, F., Ding, W., & Ye, S. (2020) · Medicine · doi:10.1097/md.0000000000019685 · Cited by 10
Long in the shade, glucagon re‐occupies centre court
Henquin, J. C., Accili, D., Åhrén, B., Boîtard, C., Seino, S., & Cerasi, E. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01476.x · Cited by 10
Knop, F. K. (2018) · Endocrine Abstracts · doi:10.1530/endoabs.56.eje1 · Cited by 10
Mirasierra, M., & Vallejo, M. (2016) · Diabetologia · doi:10.1007/s00125-015-3849-4 · Cited by 9
Reinhard, M., Frystyk, J., Jespersen, B., Randers, E., Bibby, B. M., & Ivarsen, P. (2015) · Clinical Endocrinology · doi:10.1111/cen.12737 · Cited by 9
Alpha Cell Stimulus-Secretion Coupling and Intercellular Interactions in Health and Type 2 Diabetes
Pohorec, V., Zadravec, N., Turk, M., Dolenšek, J., & Stožer, A. (2023) · Acta Medico-Biotechnica · doi:10.18690/actabiomed.246 · Cited by 9
G6PC2 controls glucagon secretion by defining the set point for glucose in pancreatic α cells
Bahl, V., Waite, E., Rifkind, R., Hamdan, Z., May, C. L., Manduchi, E., Voight, B. F., Lee, M. Y. Y., Tigue, M., Manuto, N., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adi6148 · Cited by 9
Huang, W., Xie, C., Albrechtsen, N. J. W., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2023) · Peptides · doi:10.1016/j.peptides.2023.170941 · Cited by 9
Physiological and Pathophysiological Control of Glucagon Secretion by Pancreatic α-Cells
Gilon, P., Cheng, R., Lai, B. K., Chae, H., & Gómez-Ruiz, A. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_37-2 · Cited by 9
Li, H., Liu, T., Lim, J., Gounko, N. V., Hong, W., & Han, W. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.01.001 · Cited by 10
Okajima, F., Emoto, N., Kato, K., & Sugihara, H. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.32409 · Cited by 9
The Role of Glucagon in Postprandial Hyperglycemia—The Jury’s Still Out
Bollyky, J., & Greenbaum, C. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1312 · Cited by 9
Coate, K. C., Dai, C., Singh, A., Stanley, J. E., Covington, B. A., Bradley, A. M., Oladipupo, F. O., Gong, Y., Wisniewski, S., Sellick, K., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102050 · Cited by 8
Batool, M., Farman, M. T., Ghaffari, A. S., Nisar, K. S., & Munjam, S. R. (2024) · Scientific Reports · doi:10.1038/s41598-024-58132-5 · Cited by 8
Tao, Y., & Liang, X. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00001-6 · Cited by 8
PIMT regulates hepatic gluconeogenesis in mice
Kapadia, B. B., Behera, S., Kumar, S. T., Shah, T., Edwin, R. K., Babu, P. P., Chakrabarti, P., Parsa, K. V. L., & Misra, P. (2023) · iScience · doi:10.1016/j.isci.2023.106120 · Cited by 8
DPP-4 inhibitor des-F-sitagliptin treatment increased insulin exocytosis from db/db mice β cells
Nagamatsu, S., Ohara‐Imaizumi, M., Nakamichi, Y., Aoyagi, K., & Nishiwaki, C. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.119 · Cited by 8
Expanding Treatment Options for Type 2 Diabetes The Old and the New
Pratley, R. E. (2009) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721709331522 · Cited by 8
Moreno-Lopez, M., Louvet, I., Delalleau, N., Acosta-Montalvo, A., Thévenet, J., Pasquetti, G., Gmyr, V., Kerr-Conte, J. A., Pattou, F. N., Bonner, C., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16089 · Cited by 7
Ndour, M. A., Lèye, A., Codou, F. B., Mohamed, L. Y., Nafy, N., Diack, N. D., Fall, A., Alassane, M., Diao, M., & Therese, D. M. (2017) · Open Journal of Internal Medicine · doi:10.4236/ojim.2017.73007 · Cited by 7
Subramanian, V., Sherman, A., Holst, J. J., Knop, F. K., Vilsbøll, T., & Bagger, J. I. (2025) · Diabetologia · doi:10.1007/s00125-025-06524-1 · Cited by 6
Altıok, M. S., Çetin, A., Kuzu, B., & Bildirici, İ. (2023) · Russian Journal of General Chemistry · doi:10.1134/s1070363223030210 · Cited by 6
The Yin Yang of Hormones that Control Glucose Homeostasis in Asthma
Insuela, D. B. R. (2013) · Journal of Allergy & Therapy · doi:10.4172/2155-6121.s11-001 · Cited by 6
Zhang, B., Chen, Y., Yang, Z., Wang, X., & Li, G. (2016) · Journal of International Medical Research · doi:10.1177/0300060516668433 · Cited by 6
Kahn, S. E., Edelstein, S. L., Arslanian, S. A., Barengolts, E., Caprio, S., Ehrmann, D. A., Hannon, T. S., Marcovina, S. M., Mather, K. J., Nadeau, K. J., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0461 · Cited by 6
Partial Inhibition of Insulin Secretion Results in Glucose Intolerance but Not Hyperglucagonemia
Ramanathan, R., Arbeláez, A. M., & Cryer, P. E. (2011) · Diabetes · doi:10.2337/db10-1586 · Cited by 6
Dehydration-induced AVP stimulates glucagon release and ketogenesis
Hill, T. G., Briant, L. J. B., Kim, A., Wu, Y., Rorsman, P., Asterholm, I. W., & Benrick, A. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00505.2024 · Cited by 5
Kouketsu, T., Monma, R., Miyairi, Y., Sawatsubashi, S., Shima, H., Igarashi, K., Sugawara, A., & Yokoyama, A. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.04.133 · Cited by 5
FeCl3-catalysed C-N coupling reaction between cyclic ethers and heterocyclic amines
Mani, S., Mohamed, M. A. F., Karakkakal, A. K., & Khan, S. A. P. M. (2014) · European Journal of Chemistry · doi:10.5155/eurjchem.5.4.612-617.1108 · Cited by 5
A bright future for glucagon and alpha cell biology
Panzer, J. K., & Caicedo, A. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0315 · Cited by 5
Cooperberg, B. A., & Cryer, P. (2010) · Diabetes · doi:10.2337/db10-0750 · Cited by 4
Chen, S., Santomango, T. S., Williams, P. E., Lacy, D. B., & McGuinness, O. P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90821.2008 · Cited by 5
The impact of low alcohol consumption on the liver and inflammatory cytokines in diabetic rats
Al‐Humadi, H., Al‐Saigh, R., & Sahib, A. S. (2018) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/77085 · Cited by 5
D’Souza, N. C., ALEALI, N., Shakeri, D., ATHERLEY, S. C., Hoffman, E. G., KARIMI-CHAHARTASH, S., JAVANBAKHSH, S., Chan, O. T. M., Liggins, R., & Riddell, M. C. (2026) · Endocrinology · doi:10.1210/endocr/bqaf192 · Cited by 4
Metadata
- Authors
- Dunning, B. E., & Gerich, J. E.
- Affiliations
- PharmaWrite, Princeton, New Jersey 08540
- University of Rochester Medicine (US)
- Corresponding author
- Gerich, John E.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2007-04-04
- Volume
- 28
- Issue
- 3
- Pages
- 253-283
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2088987697
- Cited by
- 369
- References
- 323
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 16 · 2023: 17 · 2022: 14 · 2021: 20 · 2020: 15 · 2019: 21 · 2018: 17 · 2017: 24 · 2016: 25 · 2015: 23 · 2014: 24 · 2013: 27 · 2012: 27
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Sanofi
- University of Rochester
- Kowa Company
- Eisai
- Novo Nordisk
- Medical Center, University of Rochester
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- glucagon, alpha cells, type 2 diabetes, fasting hyperglycemia, postprandial hyperglycemia, hyperglucagonemia, glucagon receptor antagonists, somatostatin, GLP-1 receptor agonists, DPP-4 inhibitors, glucagon secretion, glycemic control, glucoregulation
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Fasting, Glucagon, Humans, Hyperglycemia, Receptors, Glucagon, Postprandial Period, Glucagon-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.